AGM/EGM12 Jun 2026, 05:21 pm
Shukra Pharmaceuticals Ltd to hold EGM on July 6, 2026
AI Summary
Shukra Pharmaceuticals Ltd has announced an Extra Ordinary General Meeting (EGM) to be held on July 6, 2026, via Video Conferencing. The primary agenda is to seek shareholder approval for a preferential issue of 46,43,000 Convertible Equity Warrants to promoters. This move is in accordance with SEBI (ICDR) Regulations, 2018, and other applicable laws. The meeting will also address other businesses as may be decided by the Board.
Key Highlights
- EGM scheduled for July 6, 2026, via VC/OAVM.
- Key agenda: Approval for preferential issue of 46,43,000 warrants.
- Issue is to promoters for cash consideration.
- Compliant with SEBI ICDR Regulations, 2018.
Price Impact
More from SHUKRAPHAR